Jonathan S Weiss MD
Assistant Clinical Professor of Dermatology, Emory University
Join to View Full Profile
2383 Pate St NSnellville, GA 30078
Phone+1 770-972-4845
Fax+1 770-972-0358
Are you Dr. Weiss?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jonathan Weiss, MD is a board certified dermatologist in Snellville, Georgia. He is currently licensed to practice medicine in Georgia, Michigan, and Michigan. He is an Assistant Clinical Professor of Dermatology at Emory University.
Education & Training
University of MichiganResidency, Dermatology, 1985 - 1988- University of MichiganInternship, Internal Medicine, 1984 - 1985
University of Michigan Medical SchoolClass of 1984
Certifications & Licensure
GA State Medical License 1987 - 2027
MI State Medical License 1986 - 1999- MI State Medical License 1986 - 1999
American Board of Dermatology Dermatology
Publications & Presentations
PubMed
- Recommendations to Improve Outcomes in Acne and Acne Sequelae: A Focus on Trifarotene and Other Retinoids.Naiem Issa, Andrew Alexis, Hilary Baldwin, Iltefat Hamzavi, Adelaide Hebert
Dermatology and Therapy. 2025-03-01 - A call to action: The need to update population descriptors in dermatology research studies with the use of an inclusive skin classification system.Valerie M Harvey, Stafford G Brown 3rd, Cheryl M Burgess, Angel S Byrd, Caryn B C Cobb
Journal of the American Academy of Dermatology. 2025-01-21 - Secukinumab in adult patients with lichen planus: efficacy and safety results from the randomized placebo-controlled proof-of-concept PRELUDE study.Thierry Passeron, Maximilian Reinhardt, Benjamin Ehst, Jonathan Weiss, Jason Sluzevich
The British Journal of Dermatology. 2024-10-17
Press Mentions
FDA Approves Use of up to Three Tubes of Biofrontera Inc.’S Ameluz (Aminolevulinic Acid HCI) Topical Gel, 10% in One TreatmentOctober 7th, 2024- Large Cohort Study Finds Isotretinoin Not Associated with IBDFebruary 6th, 2023
- Georgia Dermatology PartnersJuly 25th, 2022
